News

Medical Research Council (MRC): Cancer Immunotherapy Response Research Platform

Medical Research Council (MRC): Cancer Immunotherapy Response Research Platform
Funding news

Apply for funding to develop a broad utility, deep genotyping and phenotyping platform capable of generating insights into patient response, adverse effects, and resistance to immunotherapy, and exemplar project(s) to demonstrate utility.

The platform will be led by a multi-organisational and multidisciplinary consortium, including at least one industry partner.

A total of £9 million (80% Full Economic cost (FEC) including relevant indexing) over four years is available with £4 million in FY 2024/25.

You must be a researcher employed at a research organisation eligible to apply for Medical Research Council (MRC) funding.


Opportunity status: Open

Funders: Medical Research Council (MRC)

Co-funders: Office of Life Sciences

Funding type: Grant

Total fund: £9,000,000

Maximum award: £9,000,000

Publication date: 9 January 2024

Opening date: 25 January 2024 9:00am UK time

Closing date: 9 May 2024 4:00pm UK time

NEWS​

Related News

Dive into the Future of Healthcare with the Essentials of Digital Health Certificate Course!

18 Jul 2024
“You are going to hit a zone of professional irrelevance if you do not know Digital Health.”  ~ Dr. Rajendra Pratap Gupta, Chairman, Academy of Digita...

The report for the 2nd Africa Women’s Health Symposium is now available!

17 Jul 2024
For over half a decade, Africa Health Business has convened stakeholders from across the African health sector to address and find solutions to critic...

Join the Africa Digital Health Revolution with ADHN

17 Jul 2024
The Africa Digital Health Network (ADHN) invites all stakeholders in health and technology to join us in revolutionizing healthcare across the contine...

Have your say: Open Public Consultation for the BeWell Skills Strategy

17 Jul 2024

Fit 4 Start #15 open to healthtech, digital, and space startups

16 Jul 2024
For its 15th edition, Luxembourg’s startup accelerator Fit 4 Start is accepting applications from innovative healthtech, digital, and space enterprise...

Rivne Interregional Medical Cluster became a member of the project consortium PRECISEU

16 Jul 2024
Ukraine, represented by the Rivne Interregional Medical Cluster, became a member of the project consortium PRECISEU

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *